Last 7 days
26%
Last 30 days
29.0%
Last 90 days
9.2%
Trailing 12 Months
200.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 3.9B | 0 | 0 | 0 |
2023 | 4.1B | 4.1B | 4.0B | 3.9B |
2022 | 4.1B | 4.1B | 4.2B | 4.2B |
2021 | 4.1B | 4.1B | 4.1B | 4.1B |
2020 | 4.0B | 4.0B | 4.0B | 4.0B |
2019 | 4.0B | 4.0B | 4.0B | 4.0B |
2018 | 3.9B | 3.9B | 3.9B | 4.0B |
2017 | 4.0B | 3.9B | 3.9B | 3.9B |
2016 | 4.0B | 4.1B | 4.0B | 4.0B |
2015 | 3.9B | 4.0B | 4.0B | 4.0B |
2014 | 3.8B | 3.7B | 3.8B | 3.9B |
2013 | 4.4B | 4.3B | 4.1B | 3.9B |
2012 | 4.4B | 4.4B | 4.4B | 4.5B |
2011 | 4.2B | 4.3B | 4.3B | 4.3B |
2010 | 4.2B | 4.2B | 4.2B | 4.2B |
2009 | 0 | 4.2B | 4.2B | 4.2B |
2008 | 0 | 0 | 0 | 4.2B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 05, 2024 | lowell kevin r | acquired | - | - | 16,510 | evp, chief people officer |
Apr 05, 2024 | chambers douglas w | acquired | - | - | 31,111 | evp-cfo & treasurer |
Apr 05, 2024 | lowell kevin r | sold (taxes) | -183,642 | 35.5 | -5,173 | evp, chief people officer |
Apr 05, 2024 | therivel laurent c | sold (taxes) | -1,826,970 | 35.5 | -51,464 | president and ceo |
Apr 05, 2024 | irizarry michael | acquired | - | - | 42,866 | evp-cto |
Apr 05, 2024 | therivel laurent c | acquired | - | - | 116,168 | president and ceo |
Apr 05, 2024 | chambers douglas w | sold (taxes) | -477,936 | 35.5 | -13,463 | evp-cfo & treasurer |
Apr 05, 2024 | irizarry michael | sold (taxes) | -674,216 | 35.5 | -18,992 | evp-cto |
Apr 03, 2024 | therivel laurent c | sold (taxes) | -623,465 | 36.85 | -16,919 | president and ceo |
Apr 03, 2024 | therivel laurent c | acquired | - | - | 38,190 | president and ceo |
Which funds bought or sold USM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 13, 2024 | Creative Planning | reduced | -1.37 | -35,508 | 230,681 | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | reduced | -60.09 | -2,642,000 | 1,427,000 | -% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | added | 5.11 | -464,198 | 5,612,680 | -% |
May 13, 2024 | Jump Financial, LLC | reduced | -70.97 | -587,962 | 201,298 | 0.01% |
May 13, 2024 | Pathstone Holdings, LLC | reduced | -80.37 | -1,040,740 | 216,921 | -% |
May 13, 2024 | FMR LLC | reduced | -0.8 | -1,351,340 | 9,177,630 | -% |
May 13, 2024 | Atria Wealth Solutions, Inc. | unchanged | - | -46,872 | 339,450 | -% |
May 13, 2024 | CLEAR STREET MARKETS LLC | sold off | -100 | -105,000 | - | -% |
May 13, 2024 | UBS Group AG | reduced | -72.45 | -1,508,690 | 481,946 | -% |
May 13, 2024 | Balyasny Asset Management L.P. | sold off | -100 | -396,125 | - | -% |
Unveiling United States Cellular Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to United States Cellular Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
TMUS | 190.3B | 78.5B | 21.74 | 2.42 | ||||
VZ | 170.6B | 134.0B | 15.09 | 1.27 | ||||
T | 124.0B | 122.3B | 11.83 | 1.01 | ||||
CHTR | 40.2B | 54.6B | 8.49 | 0.74 | ||||
MID-CAP | ||||||||
CCOI | 2.9B | 1.1B | 2.39 | 2.72 | ||||
IDCC | 2.7B | 610.8M | 14.08 | 4.39 | ||||
GSAT | 2.3B | 221.6M | -66.15 | 10.28 | ||||
CABO | 2.2B | 1.7B | 8.71 | 1.35 | ||||
SMALL-CAP | ||||||||
ATUS | 965.9M | 9.2B | 157.32 | 0.11 | ||||
ATEX | 596.0M | 3.5M | 37.66 | 168.4 | ||||
CNSL | 511.6M | 1.1B | -1.81 | 0.46 | ||||
ATNI | 401.9M | 763.2M | -20.46 | 0.53 | ||||
CXDO | 99.6M | 55.0M | 60.21 | 1.81 | ||||
DISH | - | 15.3B | - | - |
United States Cellular Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -5.0% | 950 | 1,000 | 963 | 957 | 986 | 1,049 | 1,083 | 1,027 | 1,010 | 1,069 | 1,016 | 1,014 | 1,023 | 1,074 | 1,027 | 973 | 963 | 1,052 | 1,031 | 973 | 966 |
Operating Expenses | -8.1% | 899 | 978 | 906 | 923 | 960 | 1,076 | 1,098 | 987 | 939 | 1,064 | 971 | 978 | 939 | 1,069 | 962 | 920 | 913 | 1,055 | 1,011 | 943 | 902 |
S&GA Expenses | -5.0% | 331 | 349 | 333 | 341 | 345 | 376 | 369 | 339 | 325 | 361 | 346 | 334 | 305 | 375 | 335 | 323 | 335 | 379 | 358 | 344 | 326 |
EBITDA Margin | 2.8% | 0.25* | 0.25* | 0.23* | 0.21* | 0.21* | 0.22* | 0.23* | 0.25* | 0.25* | 0.25* | 0.25* | 0.26* | 0.26* | 0.26* | 0.26* | 0.25* | 0.25* | 0.25* | 0.25* | 0.25* | 0.25* |
Interest Expenses | -11.3% | 43.00 | 49.00 | 50.00 | 51.00 | 47.00 | 48.00 | 42.00 | 40.00 | 33.00 | 31.00 | 45.00 | 60.00 | 39.00 | 35.00 | 29.00 | 25.00 | 24.00 | 23.00 | 29.00 | 29.00 | 29.00 |
Income Taxes | 900.0% | 28.00 | -3.50 | 27.00 | 19.00 | 11.00 | -9.50 | -3.00 | 18.00 | 32.00 | -11.00 | 14.00 | -10.00 | 27.00 | 6.00 | 4.00 | 4.00 | 4.00 | -3.50 | 15.00 | 14.00 | 27.00 |
Earnings Before Taxes | 333.3% | 52.00 | 12.00 | 50.00 | 24.00 | 25.00 | -36.50 | -15.00 | 40.00 | 84.00 | 17.00 | 49.00 | 25.00 | 89.00 | 12.00 | 89.00 | 73.00 | 76.00 | 15.00 | 39.00 | 46.00 | 85.00 |
EBT Margin | 25.5% | 0.04* | 0.03* | 0.02* | 0.00* | 0.00* | 0.02* | 0.03* | 0.05* | 0.04* | 0.04* | 0.04* | 0.05* | 0.06* | 0.06* | 0.06* | 0.05* | 0.04* | 0.05* | 0.05* | 0.05* | 0.06* |
Net Income | 33.3% | 18.00 | 14.00 | 23.00 | 5.00 | 13.00 | -28.00 | -12.00 | 21.00 | 49.00 | 27.00 | 34.00 | 35.00 | 60.00 | 5.00 | 85.00 | 68.00 | 71.00 | 19.00 | 23.00 | 31.00 | 54.00 |
Net Income Margin | 10.2% | 0.02* | 0.01* | 0.00* | -0.01* | 0.00* | 0.01* | 0.02* | 0.03* | 0.04* | 0.04* | 0.03* | 0.04* | 0.05* | 0.06* | 0.06* | 0.04* | 0.04* | 0.03* | 0.03* | 0.04* | 0.04* |
Free Cashflow | 1100.0% | 70.00 | -7.00 | 226 | 194 | -155 | -13.00 | -47.00 | 129 | 161 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -0.4% | 10,704 | 10,750 | 10,749 | 10,889 | 10,997 | 11,119 | 11,056 | 11,003 | 10,875 | 10,341 | 10,144 | 9,920 | 10,148 | 9,681 | 9,180 | 8,500 | 8,251 | 8,164 | 8,291 | 8,223 | 8,229 |
Current Assets | -0.4% | 1,395 | 1,400 | 1,393 | 1,500 | 1,562 | 1,723 | 1,675 | 1,673 | 1,611 | 1,605 | 1,571 | 1,645 | 1,845 | 2,623 | 2,289 | 1,718 | 1,576 | 1,573 | 1,770 | 1,735 | 1,839 |
Cash Equivalents | 40.0% | 210 | 150 | 153 | 186 | 154 | 273 | 289 | 355 | 344 | 199 | 263 | 297 | 512 | 1,291 | 948 | 436 | 267 | 291 | 575 | 532 | 652 |
Inventory | -12.1% | 175 | 199 | 175 | 210 | 262 | 261 | 243 | 206 | 177 | 173 | 136 | 183 | 139 | 146 | 157 | 145 | 212 | 162 | 139 | 146 | 157 |
Net PPE | -1.4% | 2,540 | 2,576 | 2,593 | 2,640 | 2,658 | 2,624 | 2,631 | 2,671 | 2,576 | 2,606 | 2,457 | 2,386 | 2,419 | 2,466 | 2,322 | 2,258 | 2,268 | 2,207 | 2,144 | 2,154 | 2,137 |
Liabilities | -100.0% | - | 108 | 104 | 106 | 107 | 166 | 163 | 162 | 157 | 96.00 | 87.00 | 84.00 | 85.00 | 84.00 | 90.00 | 85.00 | - | 87.00 | - | - | - |
Current Liabilities | -7.1% | 837 | 901 | 1,031 | 1,008 | 953 | 1,195 | 1,099 | 982 | 873 | 903 | 856 | 751 | 739 | 871 | 730 | 697 | 722 | 750 | 849 | 747 | 802 |
Long Term Debt | -0.5% | 3,029 | 3,044 | 2,903 | 3,105 | 3,297 | 3,187 | 3,115 | 3,118 | 3,220 | 2,728 | 2,604 | 2,710 | 2,981 | 2,489 | 2,108 | 1,625 | 1,503 | 1,502 | 1,592 | 1,596 | 1,601 |
Shareholder's Equity | 1.0% | 4,673 | 4,626 | 4,603 | 4,589 | 4,583 | 4,554 | 4,605 | 4,624 | 4,609 | 4,563 | 4,539 | 4,519 | 4,490 | 4,426 | 4,426 | 4,334 | 4,264 | 4,210 | 4,185 | 4,175 | 4,134 |
Retained Earnings | 0.6% | 2,910 | 2,892 | 2,878 | 2,855 | 2,872 | 2,861 | 2,890 | 2,903 | 2,897 | 2,849 | 2,822 | 2,794 | 2,796 | 2,739 | 2,736 | 1.00 | -1.00 | -2.00 | 2,532 | 2,509 | 2.00 |
Additional Paid-In Capital | 0.8% | 1,740 | 1,726 | 1,717 | 1,710 | 1,704 | 1,703 | 1,696 | 1,692 | 1,685 | 1,678 | 1,671 | 1,663 | 1,657 | 1,651 | 1,654 | 1,646 | 1,636 | 1,629 | 1,622 | 1,615 | 1,599 |
Accumulated Depreciation | -17.2% | 5,781 | 6,984 | 6,978 | 6,851 | 6,782 | 6,710 | 6,779 | 6,681 | 6,560 | 6,450 | 6,533 | 6,488 | 6,404 | 6,319 | 6,301 | 6,223 | 6,217 | 6,086 | 5,944 | 5,826 | 5,730 |
Shares Outstanding | 0% | 85.00 | 85.00 | 85.00 | 85.00 | 85.00 | 85.00 | 86.00 | 86.00 | 86.00 | 86.00 | 87.00 | 87.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.00 | 87.00 | 86.00 |
Minority Interest | -6.2% | 15.00 | 16.00 | 16.00 | 16.00 | 15.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 15.00 | 15.00 | 15.00 | 13.00 | 12.00 | 13.00 | 13.00 | 13.00 | 13.00 |
Float | - | - | - | - | 252 | - | - | - | 428 | - | - | - | 575 | - | - | - | 463 | - | - | - | 703 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 38.1% | 203 | 147 | 329 | 349 | 41.00 | 180 | 74.00 | 267 | 311 | 135 | 304 | 239 | 124 | 287 | 258 | 350 | 342 | 37.00 | 211 | 189 | 287 |
Share Based Compensation | 44.4% | 13.00 | 9.00 | 8.00 | 6.00 | - | 6.00 | 4.00 | 7.00 | 7.00 | 7.00 | 8.00 | 6.00 | 6.00 | 7.00 | 8.00 | 10.00 | 7.00 | 9.00 | 7.00 | 16.00 | 9.00 |
Cashflow From Investing | 44.0% | -144 | -257 | -119 | -153 | -192 | -203 | -125 | -141 | -710 | -304 | -198 | -146 | -1,388 | -308 | -224 | -289 | -342 | -217 | -141 | -294 | -212 |
Cashflow From Financing | -126.9% | -28.00 | 104 | -249 | -172 | 43.00 | 42.00 | -15.00 | -115 | 544 | 105 | -140 | -308 | 485 | 364 | 478 | 108 | -24.00 | -104 | -27.00 | -15.00 | -6.00 |
Buy Backs | - | - | - | - | - | - | 15.00 | 10.00 | 8.00 | 10.00 | 10.00 | 19.00 | - | 2.00 | - | - | 2.00 | 21.00 | - | 21.00 | - | - |
Consolidated Statement of Operations - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating revenues | ||
Total operating revenues | $ 950 | $ 986 |
Operating expenses | ||
Selling, general and administrative | 331 | 345 |
Depreciation, amortization and accretion | 165 | 170 |
(Gain) loss on asset disposals, net | 6 | 10 |
(Gain) loss on license sales and exchanges, net | (1) | 0 |
Total operating expenses | 899 | 960 |
Operating income | 51 | 26 |
Investment and other income (expense) | ||
Equity in earnings of unconsolidated entities | 42 | 44 |
Interest and dividend income | 2 | 2 |
Interest expense | (43) | (47) |
Total investment and other income (expense) | 1 | (1) |
Income before income taxes | 52 | 25 |
Income tax expense | 28 | 11 |
Net income | 24 | 14 |
Less: Net income attributable to noncontrolling interests, net of tax | 6 | 1 |
Net income attributable to UScellular shareholders | $ 18 | $ 13 |
Basic weighted average shares outstanding (in shares) | 85 | 85 |
Basic earnings per share attributable to UScellular shareholders | $ 0.21 | $ 0.15 |
Diluted weighted average shares outstanding (in shares) | 88 | 86 |
Diluted earnings per share attributable to UScellular shareholders | $ 0.20 | $ 0.15 |
Service | ||
Operating revenues | ||
Total operating revenues | $ 754 | $ 767 |
Operating expenses | ||
Cost of goods and services | 182 | 182 |
Equipment sales | ||
Operating revenues | ||
Total operating revenues | 196 | 219 |
Operating expenses | ||
Cost of goods and services | $ 216 | $ 253 |
Consolidated Balance Sheet - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 | ||
---|---|---|---|---|
Current assets | ||||
Cash and cash equivalents | $ 185 | $ 150 | ||
Accounts receivable | ||||
Customers and agents, less allowances of $62 and $66, respectively | 877 | 900 | ||
Other, less allowances of $3 and $4, respectively | 53 | 54 | ||
Inventory, net | 175 | 199 | ||
Prepaid expenses | 71 | 57 | ||
Income taxes receivable | 0 | 1 | ||
Other current assets | 32 | 36 | ||
Total current assets | 1,395 | 1,400 | ||
Assets held for sale | 0 | 15 | ||
Licenses | 4,711 | 4,693 | ||
Investments in unconsolidated entities | 482 | 461 | ||
Property, plant and equipment | ||||
In service and under construction | 8,321 | 9,560 | ||
Less: Accumulated depreciation and amortization | 5,781 | 6,984 | ||
Property, plant and equipment, net | 2,540 | 2,576 | ||
Operating lease right-of-use assets | 910 | 915 | ||
Other assets and deferred charges | 666 | 690 | ||
Total assets | [1] | 10,704 | 10,750 | |
Current liabilities | ||||
Current portion of long-term debt | 20 | 20 | ||
Accounts payable | ||||
Accounts payable - Trade | 224 | 241 | ||
Customer deposits and deferred revenues | 235 | 229 | ||
Accrued taxes | 49 | 32 | ||
Accrued compensation | 32 | 83 | ||
Short-term operating lease liabilities | 134 | 135 | ||
Other current liabilities | 138 | 154 | ||
Total current liabilities | 837 | 901 | ||
Deferred liabilities and credits | ||||
Deferred income tax liability, net | 758 | 755 | ||
Long-term operating lease liabilities | 827 | 831 | ||
Other deferred liabilities and credits | 564 | 565 | ||
Long-term debt, net | 3,029 | 3,044 | ||
Commitments and contingencies | ||||
Noncontrolling interests with redemption features | 16 | 12 | ||
UScellular shareholders’ equity | ||||
Series A Common and Common Shares Authorized 190 shares (50 Series A Common and 140 Common Shares) Issued 88 shares (33 Series A Common and 55 Common Shares) Outstanding 85 shares (33 Series A Common and 52 Common Shares) Par Value ($1.00 per share) ($33 Series A Common and $55 Common Shares) | 88 | 88 | ||
Additional paid-in capital | 1,740 | 1,726 | ||
Treasury shares, at cost, 3 Common Shares | (80) | (80) | ||
Retained earnings | 2,910 | 2,892 | ||
Total UScellular shareholders' equity | 4,658 | 4,626 | ||
Noncontrolling interests | 15 | 16 | ||
Total equity | 4,673 | 4,642 | ||
Total liabilities and equity | [1] | 10,704 | 10,750 | |
Affiliated | ||||
Accounts receivable | ||||
Affiliated | 2 | 3 | ||
Accounts payable | ||||
Accounts payable - Affiliated | $ 5 | $ 7 | ||
|